BD Insyte-N™ Autoguard™ Shielded IV Catheter
Designed specifically for neonates

Features and Benefits

• Designed Specifically for Neonates
• BD Instaflash™ Needle Technology
• Improved First-Start Efficiency
• Maximized Indwelling Time
• Proven to Reduce Needlestick Injuries
• Shielding Technology
• Catheter Tip
• References

Designed Specifically for Neonates

Feedback from clinicians using the BD Insyte-N Autoguard shielded IV catheter indicated that it is best designed for the neonatal patient population. Comments from clinicians included:

• "The size makes these catheters easier to use on smaller babies."
• "Yes for smaller babies - especially 2kg or less."
• "The shorter needle/catheter is good in preemie situations and small extremes and short areas to work with."
• "Insyte-N Autoguard would be excellent for premature, very low birth weight infants or any infant with small curly veins."
• "I think the catheter will work very well for our small preemies and and hard IV access babies."

BD Instaflash Needle Technology

Features:

The unique notched needle provides immediate visualization of blood return along the catheter shaft. When placing a catheter in a neonate with small or compromised veins, the instant confirmation of blood return along the catheter increases the clinician's ability to successfully access the vein.

Benefits:

• The BD Instaflash needle technology provides immediate confirmation of vessel entry which provides added confidence when accessing the veins of neonates.
• The overall insertion force of the needle is low, causing less pain during insertion.
• The modified B-bevel cutting edge makes a smaller incision, which may result in less site bleeding and faster healing.

Top of Page

Improved First-Start Efficiency

Features:

At 0.56 inches, BD Insyte-N Autoguard shielded IV catheter is the shortest safety-engineered IV catheter available. Both winged and straight catheters are engineered for easy handling and a smooth insertion to minimize trauma and reduce restarts.

Benefits:

• Catheter easier to get into the vein.
• With a shorter catheter, there's less chance of blowing the vein.

Top of Page

Maximized Indwelling Time

Features:

BD Insyte-N Autoguard shielded IV catheters are made of BD Vialon™ biomaterial, clinically proven to be easier to insert, while demonstrating superior indwelling characteristics to enhance the outcome of neonatal IV therapy. In neonates, peripheral IV dwell times only "average 27-49 hours," and "up to 91% of peripheral devices in very low birth weight neonates are removed for complications." Less traumatic insertions and a biocompatible catheter material can improve these statistics.

Benefits:

• BD Vialon catheter material reduced the risk of infiltration by 18% in the total sample and by 35% in the higher risk low-weight subsample.
• On average, BD Vialon biomaterial remained in situ for 9 additional hours, or 21% longer than FEP before infiltration.
  

Top of Page

Proven to Reduce Needlestick Injuries

Results of an Autoguard Effectiveness Study conducted by Mt. Sinai Medical Center in New York, NY, a 1,000-bed teaching hospital, clinically proved the BD Insyte Autoguard shielded IV catheter to reduce needlestick injuries by 95%. The BD Autoguard technology is the only safety-engineered catheter proven to demonstrate effective needlestick reduction.

Shielding Technology

Features:

The unique, patented activation mechanism of the BD Insyte-N Autoguard shielded IV catheter is a mechanical design in which the button holds the needle assembly in the forward position until the user activates the device. Pressing the button releases the spring and allows the needle and flash chamber to retract quickly into the safety barrel.

Benefits:

• Allows user to determine when to activate the safety mechanism. Clinician maintains control of the process which is especially important with the clinicians placing catheters in neonatal infants.
• Activation of the needle shielding mechanism can be confirmed by sight.
• Offers a high degree of safety in two areas: 1) needlestick injury and 2) blood exposure.

Top of Page

Catheter Tip

Features:

The patented low-profile symmetrical tip allows a minimum of resistance as the tissue transitions from the needle bevel onto the catheter.

Benefits:

• The patented catheter tip may result in an ultra-smooth penetration, greater first start efficiency, reduced catheter peelback, and less pain and trauma to the patient.

Top of Page

References

• Data on file at BD
• Pettit, J., Hughes, K., "Neonatal Intravenous Therapy Practices" Journal of Vascular Access Devices, Spring, 1999, pages 7-16.
• Stanley M., Meister E., Fuschuber K., "Infiltration During Intravenous Therapy in Neonates: Comparison of Teflon® and Vialon™ Catheters." Southern Medical Journal, September 1992, Vol. 85, No. 9, pages 883-886.
• Ahrens, T., Wiersema, L., Weilitz, PB, "Differences in Pain Perception Associated with Intravenous Catheter Insertion", Journal of Intravenous Nursing, Vol. 14 No. 2, March/April 1991, pages 85-89.
• Gaukroger PB, Roberts JG, Manners TA. "Infusion thrombophlebitis: a prospective comparison of 645 Vialon™ and Teflon® cannulae in anaesthetic and postoperative use." Anaesth lntens Care 1988; 16:265-271
• Maki DG, Ringer M. "Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial." Ann Intern Med 1991; 114:845-854
• McKee JM, Shell JA, Warren TA, Campbell VP. "Complications of intravenous therapy: a randomized prospective study--Vialon™ vs. Teflon®." Journal of Intravenous Nursing 1989; 12(5): 288-295.

Clinical Resource Materials
Points to Consider

Top of Page